US Stocks
/
BridgeBio Pharma, Inc. Share Price
BridgeBio Pharma, Inc. Share Price

BridgeBio Pharma, Inc. Share Price

NASDAQ: BBIO | Large Cap
$64.99
-$1.62 (-2.42%) Last updated on 09 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

BridgeBio Pharma, Inc. Stock Performance

Open
$66.39
Prev. Close
$66.61
Circuit Range
N/A
Day Range
$63.72 - $66.39
Year Range
$52.76 - $93.17
Volume
2,10,774
Average Traded
$64.88

BridgeBio Pharma, Inc. Share Price Today

As of 9 October 2026, BridgeBio Pharma, Inc.'s share price is $64.99. The stock opened at $66.39, compared to its previous close of $66.61. During today's trading session, BridgeBio Pharma, Inc.'s share price traded between $63.72 and $66.39, with an average price of $65.06. Over the past 52 weeks, the stock has recorded a high of $93.17 and a low of $52.76. In terms of performance, BridgeBio Pharma, Inc.'s share price has declined by 8.68% over the last six months and is up 3.74% on a year-on-year basis.

BridgeBio Pharma, Inc. Share Price Chart

$63.72$66.39
L
Show Current Price
H

BridgeBio Pharma, Inc. Stock Fundamentals & Key Indicators

Market Cap
$12.45B
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-3.54
Revenue (TTM)
$502.08B
Return On Equity (TTM)
27.51%
Profit Margin
-144.39%
Debt to Equity
-0.98
Quarterly Earnings Growth YoY
16.70%

BridgeBio Pharma, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$120.70$154.18$194.52$243.68
Net Profit-$182.74-$192.86-$164.04-$152.22
Net Profit Margin-151.40%-125.09%-84.33%-62.47%
Income ChangeN/A-5.54%14.94%7.21%

BridgeBio Pharma, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$77.65$9.30$221.90$502.08
Net Profit-$481.18-$643.20-$535.76-$724.93
Net Profit Margin-619.68%-6916.13%-241.44%-144.39%
Income ChangeN/A-33.67%16.70%-35.31%

About BridgeBio Pharma, Inc.

BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. Its key drug is Attruby (acoramidis), an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.

BridgeBio Pharma, Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$65.66
$65.05
-1.24%
Sep 2026
$77.13
$65.86
-16.33%
Aug 2026
$80.53
$78.72
-1.69%
Jul 2026
$74.59
$80.07
+7.48%
Jun 2026
$66.50
$74.50
+12.33%
May 2026
$70.25
$66.32
-6.81%
Apr 2026
$74.77
$71.17
-4.11%
Mar 2026
$64.71
$74.22
+11.68%
Feb 2026
$76.50
$66.46
-14.04%
Jan 2026
$76.92
$77.31
+1.05%
Dec 2025
$71.91
$76.51
+6.24%
Nov 2025
$63.23
$72.02
+14.96%

BBIO Share Price FAQs

What is BridgeBio Pharma, Inc. share price today?

chevron-up
BridgeBio Pharma, Inc. share price today is $64.99 as on October 9, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of BridgeBio Pharma, Inc. stock?

chevron-up
The 52 week high of BridgeBio Pharma, Inc. stock is $93.17, while the 52 week low is $52.76 as of 9 Oct '26.

What is BBIO's market capitalisation today?

chevron-up
BBIO market capitalisation is $12.45B as of October 9, 2026, at 1:29 am IST.

What is BBIO's net income for the last quarter?

chevron-up
BBIO's net income for the last quarter is -152.22B USD.

What is the 5 year returns of BBIO?

chevron-up
The 5 year returns of BBIO is 31.59% as on 9 Oct '26.

What is the high & low stock price of BBIO today?

chevron-up
BBIO stock price hit a high of $66.39 and low of $63.72 as of 9 Oct '26.

Can I buy BBIO shares in India?

chevron-up
Yes. You can buy BBIO in India by opening an international trading account.